{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:42:58Z","timestamp":1775151778917,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,7,15]],"date-time":"2009-07-15T00:00:00Z","timestamp":1247616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1742-4690-6-67","type":"journal-article","created":{"date-parts":[[2009,7,16]],"date-time":"2009-07-16T06:13:39Z","timestamp":1247724819000},"source":"Crossref","is-referenced-by-count":20,"title":["Ethnic differences in the adaptation rate of HIV gp120 from a vaccine trial"],"prefix":"10.1186","volume":"6","author":[{"given":"Marcos","family":"P\u00e9rez-Losada","sequence":"first","affiliation":[]},{"given":"David","family":"Posada","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Arenas","sequence":"additional","affiliation":[]},{"given":"David V","family":"Jobes","sequence":"additional","affiliation":[]},{"given":"Faruk","family":"Sinangil","sequence":"additional","affiliation":[]},{"given":"Phillip W","family":"Berman","sequence":"additional","affiliation":[]},{"given":"Keith A","family":"Crandall","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,7,15]]},"reference":[{"key":"1072_CR1","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/S0140-6736(00)02360-6","volume":"355","author":"J Esparza","year":"2000","unstructured":"Esparza J, Bhamarapravati N: Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?. Lancet. 2000, 355: 2061-2066. 10.1016\/S0140-6736(00)02360-6.","journal-title":"Lancet"},{"key":"1072_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570162033352093","volume":"1","author":"P Spearman","year":"2003","unstructured":"Spearman P: HIV vaccine development: lessons from the past and promise for the future. Curr HIV Res. 2003, 1: 101-120. 10.2174\/1570162033352093.","journal-title":"Curr HIV Res"},{"key":"1072_CR3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1086\/428404","volume":"191","author":"rgp120 HIV Vaccine Study Group","year":"2005","unstructured":"rgp120 HIV Vaccine Study Group: Placebo controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. rgp120 HIV Vaccine Study Group. J Infect Dis. 2005, 191: 654-665. 10.1086\/428404.","journal-title":"J Infect Dis"},{"key":"1072_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.tim.2007.05.006","volume":"15","author":"D Eggink","year":"2007","unstructured":"Eggink D, Melchers M, Sanders RW: Antibodies to HIV-1: aiming at the right target. Trends Microbiol. 2007, 15: 291-294. 10.1016\/j.tim.2007.05.006.","journal-title":"Trends Microbiol"},{"key":"1072_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/385111a0","volume":"385","author":"PM Sharp","year":"1997","unstructured":"Sharp PM: In search of molecular Darwinism. Nature. 1997, 385: 111-112. 10.1038\/385111a0.","journal-title":"Nature"},{"key":"1072_CR6","first-page":"418","volume":"3","author":"M Nei","year":"1986","unstructured":"Nei M, Gojobori T: Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol. 1986, 3: 418-426.","journal-title":"Mol Biol Evol"},{"key":"1072_CR7","doi-asserted-by":"publisher","first-page":"11715","DOI":"10.1128\/JVI.76.22.11715-11720.2002","volume":"76","author":"HA Ross","year":"2002","unstructured":"Ross HA, Rodrigo AG: Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. J Virol. 2002, 76: 11715-11720. 10.1128\/JVI.76.22.11715-11720.2002.","journal-title":"J Virol"},{"key":"1072_CR8","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1093\/molbev\/msg144","volume":"20","author":"S Williamson","year":"2003","unstructured":"Williamson S: Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. Mol Biol Evol. 2003, 20: 1318-1325. 10.1093\/molbev\/msg144.","journal-title":"Mol Biol Evol"},{"key":"1072_CR9","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1086\/428405","volume":"191","author":"PB Gilbert","year":"2005","unstructured":"Gilbert PB, Peterson ML, Follmann D, Hudgens MG, Francis DP, Gurwith M, Heyward WL, Jobes DV, Popovic V, Self SG, et al: Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. J Infect Dis. 2005, 191: 666-677. 10.1086\/428405.","journal-title":"J Infect Dis"},{"key":"1072_CR10","volume-title":"Mol Biol Evol","author":"M P\u00e9rez-Losada","year":"2009","unstructured":"P\u00e9rez-Losada M, Jobes DV, Sinangil F, Crandall KA, Posada D, Berman PW: Phylodynamics of gp120 sequences from a Phase 3 HIV-1 vaccine trial in North America. Mol Biol Evol. 2009, in review"},{"key":"1072_CR11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/nar\/gki198","volume":"33","author":"K Katoh","year":"2005","unstructured":"Katoh K, Kuma K, Toh H, Miyata T: MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. 2005, 33: 511-518. 10.1093\/nar\/gki198.","journal-title":"Nucleic Acids Res"},{"key":"1072_CR12","first-page":"55","volume-title":"Computational and evolutionary analysis of HIV molecular sequences","author":"B Korber","year":"2000","unstructured":"Korber B: HIV signature and sequence variation analysis. Computational and evolutionary analysis of HIV molecular sequences. Edited by: Rodrigo AG, Learn GH. 2000, Dordrecht, Netherlands: Kluwer Academic Publishers, 4: 55-72."},{"key":"1072_CR13","volume-title":"PAML: Phylogenetic Analysis by Maximum Likelihood","author":"Z Yang","year":"2001","unstructured":"Yang Z: PAML: Phylogenetic Analysis by Maximum Likelihood. 2001, London: University College London, 3.1","edition":"3.1"},{"key":"1072_CR14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/bioinformatics\/bti079","volume":"21","author":"SL Kosakovsky Pond","year":"2005","unstructured":"Kosakovsky Pond SL, Frost SDW, Muse SV: HyPhy: hypothesis testing using phylogenies. Bioinformatics. 2005, 21: 676-679. 10.1093\/bioinformatics\/bti079.","journal-title":"Bioinformatics"},{"key":"1072_CR15","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1093\/bioinformatics\/btl474","volume":"22","author":"SL Kosakovsky Pond","year":"2006","unstructured":"Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SD: GARD: a genetic algorithm for recombination detection. Bioinformatics. 2006, 22: 3096-3098. 10.1093\/bioinformatics\/btl474.","journal-title":"Bioinformatics"},{"key":"1072_CR16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995, 57: 289-300.","journal-title":"J R Statist Soc B"},{"key":"1072_CR17","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/jhep.2003.50103","volume":"37","author":"K Sugimoto","year":"2003","unstructured":"Sugimoto K, Stadanlick J, Ikeda F, Brensinger C, Furth EE, Alter HJ, Chang KM: Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response. Hepatology. 2003, 37: 590-599. 10.1053\/jhep.2003.50103.","journal-title":"Hepatology"},{"key":"1072_CR18","volume-title":"HIV\/AIDS Surveillance Report","author":"CDC","year":"2007","unstructured":"CDC: HIV\/AIDS Surveillance Report. 2007, Atlanta: Centers for Disease Control and Prevention (CDC), 19:"},{"key":"1072_CR19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1086\/428406","volume":"191","author":"BS Graham","year":"2005","unstructured":"Graham BS, Mascola JR: Lessons from failure \u2013 preparing for future HIV-1 vaccine efficacy trials. J Infect Dis. 2005, 191: 647-649. 10.1086\/428406.","journal-title":"J Infect Dis"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-6-67.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1742-4690-6-67\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-6-67.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T02:34:00Z","timestamp":1739241240000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-6-67"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,15]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["1072"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-6-67","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,15]]},"article-number":"67"}}